Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Bio-Path Holdings (BPTH)

Bio-Path Holdings (BPTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Bio-Path: Q3 Earnings Snapshot AP - Wed Nov 15, 2023

Bio-Path: Q3 Earnings Snapshot

BPTH : 2.70 (-7.53%)
Bio-Path: Q2 Earnings Snapshot AP - Tue Aug 15, 2023

Bio-Path: Q2 Earnings Snapshot

BPTH : 2.70 (-7.53%)
Bio-Path: Q1 Earnings Snapshot AP - Fri May 12, 2023

Bio-Path: Q1 Earnings Snapshot

BPTH : 2.70 (-7.53%)
Bio-Path: Q3 Earnings Snapshot AP - Tue Nov 15, 2022

Bio-Path: Q3 Earnings Snapshot

BPTH : 2.70 (-7.53%)
Bio-Path Holdings to Announce Second Quarter 2022 Financial Results on August 16, 2022 Globe Newswire - Tue Aug 9, 2022

HOUSTON, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize®...

BPTH : 2.70 (-7.53%)
Bio-Path Holdings Reports First Quarter 2022 Financial Results Globe Newswire - Tue May 17, 2022

Conference Call to be Held Today at 8:30 A.M. ET...

BPTH : 2.70 (-7.53%)
Bio-Path Holdings to Announce First Quarter 2022 Financial Results on May 17, 2022 Globe Newswire - Tue May 10, 2022

HOUSTON, May 10, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense...

BPTH : 2.70 (-7.53%)
Bio-Path Holdings Presents BP1003 Data at 2022 American Association for Cancer Research Annual Meeting Globe Newswire - Tue Apr 12, 2022

Preclinical Data Support BP1003 Combination Therapy to Treat Breast and Ovarian Cancers...

BPTH : 2.70 (-7.53%)
Bio-Path Holdings Reports Full Year 2021 Financial Results Globe Newswire - Fri Mar 11, 2022

Conference Call to be Held Today at 8:30 A.M. ET...

BPTH : 2.70 (-7.53%)
Bio-Path Holdings to Present at the 2022 American Association for Cancer Research Annual Meeting Globe Newswire - Tue Mar 8, 2022

HOUSTON, March 08, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize™...

BPTH : 2.70 (-7.53%)

Barchart Exclusives

Bottom 100 Stocks to Buy: Very Aggressive Investors Might Consider a Small Wager on This Class Action Stock Barchart - 33 minutes ago
Sonder Holdings faces a potential class action lawsuit over the handling of its financial statements in 2022 and 2023. The penny stock has lost nearly 60% of its value over the past year and is in Barchart’s Bottom 100 Stocks to Buy. Yet, it could be a moneymaker for aggressive investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot